Page Image

Triple-Negative Breast Cancer

Back to Homepage
Emiltatug Ledadotin Well Tolerated in Triple-Negative Breast Cancer Phase 1b Study
Emiltatug ledadotin showed early clinical activity and was well tolerated in heavily pretreated patients with TNBC.
Advertisement

Expert Interviews

Advertisement
Advertisement
Latest Updates in Breast Cancer

May 22, 2025